| Hughes B
First oral therapies for multiple sclerosis anticipated. [Journal Article]
Nat Rev Drug Discov 2009 Nov; 8(11):831-3.
Full Citation | Find Related Articles | | Trojano M, Pellegrini F, Paolicelli D, et al.
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. [Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't]
Ann Neurol 2009 Oct; 66(4):513-20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Miller DH, Leary SM
Treatment of clinically isolated syndrome: to be PreCISe. [Comment, Journal Article]
Lancet 2009 Oct 31; 374(9700):1475-6.
Full Citation | Find Related Articles | | Comi G, Martinelli V, Rodegher M, et al.
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. [Journal Article, Research Support, Non-U.S. Gov't]
Lancet 2009 Oct 31; 374(9700):1503-11.
Abstract | Full Citation | Find Related Articles | | Kebir H, Ifergan I, Alvarez JI, et al.
Preferential recruitment of interferon-gamma-expressing T H 17 cells in multiple sclerosis. [In Vitro, Journal Article, Research Support, Non-U.S. Gov't]
Ann Neurol 2009 Sep; 66(3):390-402.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Schweikert A, Kremer M, Ringel F, et al.
Primary central nervous system lymphoma in a patient treated with natalizumab. [Case Reports, Journal Article]
Ann Neurol 2009 Sep; 66(3):403-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Salvatore E, Morra VB, Orefice G, et al.
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. [Comment, Letter]
Neurology 2009 Sep 29; 73(13):1078; author reply 1078-9.
Full Citation | Publisher Full Text | Find Related Articles | | Engel WK, Fazekas F, Lublin FD, et al.
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. [Comment, Letter]
Neurology 2009 Sep 29; 73(13):1077; author reply 1077-8.
Full Citation | Publisher Full Text | Find Related Articles | | van der Walt A, Stankovich J, Bahlo M, et al.
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. [Journal Article, Research Support, Non-U.S. Gov't]
Neurology 2009 Sep 29; 73(13):1018-25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Calabrese M, Agosta F, Rinaldi F, et al.
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. [Journal Article]
Arch Neurol 2009 Sep; 66(9):1144-50.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
